Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.
Grolez G, Moreau C, Sablonnière B, Garçon G, Devedjian JC, Meguig S, Gelé P, Delmaire C, Bordet R, Defebvre L, Cabantchik IZ, Devos D.
Grolez G, et al. Among authors: defebvre l.
BMC Neurol. 2015 May 6;15:74. doi: 10.1186/s12883-015-0331-3.
BMC Neurol. 2015.
PMID: 25943368
Free PMC article.
Clinical Trial.